Journal Selection & Manuscript Polishing Services
Medicine
Medicine
Back to journal directory
Review Cycle Records
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
60
days
Interleukin-6 in ALS: metabolic mediator or marker of ventilatory decline?
AuthorsAna Catarina Pronto-Laborinho; Mamede De Carvalho
Affiliations1. Institute of Physiology, MUHCRI and Centro de Estudos Egas Moniz, Faculty of Medicine, University of Lisbon; 2. Department of Neurosciences and Mental Health, ULS de Santa Maria, Hospital de Santa Maria
94
days
The World Federation of Neurology Specialty Group in ALS/MND: toward strategic partnership and new frontiers
AuthorsMatthew C. Kiernan; Angela Genge; Julian Grosskreutz; Satoshi Kuwabara; Patricia Lillo; Jeffrey Rosenfeld; Cathy Cummings
Affiliations1. Neuroscience Research Australia; 2. South Eastern Sydney Local Health District, University of New South Wales; 3. The Neuro at Montreal Neurological Institute-Hospital, McGill University; 4. Precision Neurology of Neuromuscular Diseases, University of Lübeck; 5. Department of Neurology, Graduate School of Medicine, Chiba University; 6. Neurology Department South division, Faculty of Medicine, Universidad de Chile; 7. Neurology Unit, Hospital San José; 8. Department of Neurology, Loma Linda University Health; 9. International Alliance of ALS/MND Associations
110
days
Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage population
AuthorsDanielle Beaulieu; Kelly Smith; Campbell Ross; Sylvia Yip; Tania C. Felizardo; Christina Fournier; Jonathan D. Glass; James D. Berry; Daniel H. Fowler; David L. Ennist; The Pooled Resource Open-Access ALS Clinical Trials Consortium
Affiliations1. Origent Data Sciences; 2. Rapa Therapeutics; 3. Emory University; 4. Mass General Hospital
47
days
ALS motor phenotypes: a revised ‘OPM’ classification
AuthorsThomas Meyer; Nicola Ticozzi; Markus Weber; John Ravits; Paul Lingor; Magdalena Kuźma-Kozakiewicz; Matthias Boentert; Torsten Grehl; Philippe Corcia; Mónica Povedano Panadés; André Maier; Caroline Ingre; Hakan Cetin; Patrick Weydt; Christian Lunetta; Leonard van den Berg; Albert C. Ludolph; David Brenner; Martin R Turner; Angela Genge
Affiliations1. Center for ALS and other Motor Neuron Disorders, Department of Neurology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; 2. APST Research; 3. Unit of Neurology, IRCCS Istituto Auxologico Italiano; 4. Department of Pathophysiology and Transplantation, Università degli Studi di Milano; 5. Neuromuscular Diseases Unit/ALS Clinic, HOCH Health Ostschweiz; 6. Department of Neurosciences, University of CA San Diego; 7. Department of Neurology, Klinikum rechts der Isar, Technical University of Munich; 8. DZNE, Deutsches Zentrum für Neurodegenerative Erkrankungen, Research Site Munich; 9. Department of Neurology, Medical University of Warsaw; 10. Neuromedizinisches Zentrum; 11. Center for ALS and other Motor Neuron Disorders, Department of Neurology, Alfried Krupp Krankenhaus; 12. Department of Neurology, Center for ALS and other Motor Neuron Disorders, CHU Bretonneau; 13. Unidad Funcional de Enfermedad de Motoneurona, Hospital Universitario de Bellvitge; 14. Department of Clinical Neuroscience, Karolinska Institute; 15. Department of Neurology, Medical University of Vienna; 16. Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna; 17. Department for Neuromuscular Disorders, Bonn University; 18. DZNE, Deutsches Zentrum für Neurodegenerative Erkrankungen, Research Site Bonn; 19. Department of Neurorehabilitation of the Milan Institute, Istituti Clinici Scientifici Maugeri IRCCS; 20. Department of Neurology, UMC Utrecht Brain Centre; 21. Department of Neurology, University Hospital Ulm; 22. Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford; 23. The Neuro at Montreal Neurological Institute-Hospital, McGill University
22
days
Tofersen treatment in SOD1 p.Leu145Phe ALS: real-world outcomes in a genetically homogeneous Croatian cohort
AuthorsHrvoje Bilić; Marin Begović; Barbara Sitaš; Mirea Hančević; Branimir Ivan Šepec; Andrea Zemba Čilić; Vedrana Peček; Kristina Gotovac Jerčić; Josipa Mateševac; Tamara Bahčić; Laura Peček; Fran Borovečki; Niko Njirić; Jakob Nemir; Marina Petrović; Ivana Jurjević; Marijan Klarica; Iveta Merćep; Ervina Bilić
Affiliations1. Department of Neurology, University Hospital Centre Zagreb; 2. Department of Neurology, General Hospital; 3. Department for Personalized Medicine, University Hospital Centre Zagreb; 4. Department of Neurosurgery, University Hospital Centre Zagreb; 5. University of Zagreb School of Medicine; 6. Department of Clinical Pharmacology, University Hospital Centre Zagreb
84
days
Cognitive and behavioral involvement in spinal and bulbar muscular atrophy (SBMA): a systematic review
AuthorsGiulia De Luca; Edoardo Nicolò Aiello; Arianna Moreschi; Beatrice Curti; Sonia Marcato; Federica Paredi; Federico Verde; Vincenzo Silani; Nicola Ticozzi; Barbara Poletti; Gianni Sorarù
Affiliations1. Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano; 2. Department of Neurosciences, MND Center, University of Padua; 3. Department of Pathophysiology and Transplantation, “Dino Ferrari” Center, Università degli Studi di Milano; 4. Department of Oncology and Hemato-Oncology, Università degli Studi di Milano
93
days
How to measure person-centred care in people living with ALS: development and validation of the patient experience PEMALS questionnaire
AuthorsAnn Katrin Schmidt; Eline W.M. Scholten; Ruben P.A. van Eijk; Conny van der Meijden; Charlotte van Esch; Johanna M.A. Visser-Meily; Leonard H. van den Berg; Anita Beelen
Affiliations1. Department of Rehabilitation, Physical Therapy Science and Sports, UMC Utrecht Brain Centre, University Medical Centre Utrecht; 2. Centre of Excellence for Rehabilitation Medicine, UMC Utrecht Brain Centre, University Medical Centre Utrecht, and De Hoogstraat Rehabilitation; 3. Department of Neurology, UMC Utrecht Brain Centre, University Medical Centre Utrecht; 4. Biostatistics & Research Support, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht; 5. ALS patiëntenvereniging; 6. Spierziekten Nederland
43
days
Bridging the gap: understanding participation barriers in ALS clinical trials through on-the-ground insights
AuthorsErica Scirocco; Allison Pogemiller Bulat; Judith R. Carey; Elisa Giacomelli; Danielle Boyce; Sabrina Paganoni; James D. Berry
Affiliations1. Harvard Medical School, Sean M. Healey and AMG Center for ALS & the Neurological Clinical Research Institute, MA General Hospital; 2. ALS ONE; 3. Johns Hopkins University School of Medicine; 4. ALS Therapy Development Institute; 5. Harvard Medical School, Spaulding Rehabilitation Hospital
48
days
Gadolinium enhancement of the cauda equina in a case of familial ALS with p.S135G SOD1 mutation
AuthorsSumika Nomizo; Junji Komatsu; Ayano Shima; Daiki Muramatsu; Keitaro Matsubara; Ichiro Nozaki; Moeko Noguchi-Shinohara; Ayumi Nishiyama; Naoki Suzuki; Masashi Aoki; Kenjiro Ono
Affiliations1. Department of Neurology, Kanazawa University Graduate School of Medical Sciences; 2. Department of Neurology, International University of Health and Welfare Shioya Hospital; 3. Department of Neurology, Tohoku University Graduate School of Medicine; 4. Department of Rehabilitation, Tohoku University Graduate School of Medicine
95
days
Subjective sleep quality in amyotrophic lateral sclerosis: a systematic review and meta-analysis
AuthorsJuyeon Oh; Seong-Il Oh
Affiliations1. College of Nursing, Dankook University; 2. Department of Neurology, Kyung Hee University Hospital, Kyung Hee University College of Medicine
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days